Literature DB >> 17599831

CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.

Venkateswaran Subramaniam1, Isabella R Vincent, Helena Gardner, Emily Chan, Helena Dhamko, Serge Jothy.   

Abstract

Colon cancer is among the leading causes of cancer death in North America. CD44, an adhesion and antiapoptotic molecule is overexpressed in colon cancer. Cofilin is involved in the directional motility of cells. In the present study, we looked at how CD44 might modulate cell migration in human colon cancer via cofilin. We used a human colon cancer cell line, HT29, which expresses CD44, HT29 where CD44 expression was knocked down by siRNA, SW620, a human colon cancer cell line which does not express CD44, stably transfected exons of CD44 in SW620 cells and the colon from CD44 knockout and wild-type mouse. Western blot analysis of siRNA CD44 lysates showed increased level of AKT phosphorylation and decreased level of cofilin expression. Similar results were also observed with SW620 cells and CD44 knockout mouse colon lysates. Experiments using the AKT phosphorylation inhibitor LY294002 indicate that AKT phosphorylation downregulates cofilin. Immunoprecipitation studies showed CD44 complex formation with Lyn, providing an essential link between CD44 and AKT phosphorylation. LY294002 also stabilized Lyn from phosphorylated AKT, suggesting an interaction between Lyn and AKT phosphorylation. Immunocytochemistry showed that cofilin and Lyn expression were downregulated in siRNA CD44 cells and CD44 knockout mouse colon. siRNA CD44 cells had significantly less migration compared to HT29 vector. Given the well-defined roles of CD44, phosphorylated AKT in apoptosis and cancer, these results indicate that CD44-induced cell migration is dependent on its complex formation with Lyn and its consequent regulation of AKT phosphorylation and cofilin expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599831     DOI: 10.1016/j.yexmp.2007.04.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  25 in total

1.  Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element.

Authors:  Karl E Miletti-González; Kyle Murphy; Muthu N Kumaran; Abhilash K Ravindranath; Roman P Wernyj; Swayamjot Kaur; Gregory D Miles; Elaine Lim; Rigel Chan; Marina Chekmareva; Debra S Heller; David Foran; Wenjin Chen; Michael Reiss; Elisa V Bandera; Kathleen Scotto; Lorna Rodríguez-Rodríguez
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

2.  Inhibition of cell proliferation by CD44: Akt is inactivated and EGR-1 is down-regulated.

Authors:  L-S Zhang; H-W Ma; H J Greyner; W Zuo; M E Mummert
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

3.  Clinical significance of pAKT and CD44v6 overexpression with breast cancer.

Authors:  Pei Yu; Ling Zhou; Weifeng Ke; Ke Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-16       Impact factor: 4.553

4.  CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.

Authors:  Matthew J Meyer; Jodie M Fleming; Amy F Lin; S Amal Hussnain; Erika Ginsburg; Barbara K Vonderhaar
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

5.  Fluorometric Quantification of Single-Cell Velocities to Investigate Cancer Metastasis.

Authors:  Erin Elizabeth Edwards; Katherine Gayle Birmingham; Meghan Jeanne O'Melia; Jaeho Oh; Susan Napier Thomas
Journal:  Cell Syst       Date:  2018-11-07       Impact factor: 10.304

6.  Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.

Authors:  F Wang; K Bhat; M Doucette; S Zhou; Y Gu; B Law; X Liu; E T Wong; J X Kang; T-C Hsieh; S Y Qian; E Wu
Journal:  Curr Mol Med       Date:  2011-08       Impact factor: 2.222

7.  CD74 is a survival receptor on colon epithelial cells.

Authors:  Nitsan Maharshak; Sivan Cohen; Frida Lantner; Gili Hart; Lin Leng; Richard Bucala; Idit Shachar
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

8.  Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer.

Authors:  Michal Sheffer; Manny D Bacolod; Or Zuk; Sarah F Giardina; Hanna Pincas; Francis Barany; Philip B Paty; William L Gerald; Daniel A Notterman; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines].

Authors:  R Pries; N Wittkopf; K Hasselbacher; B Wollenberg
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

10.  Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.

Authors:  Matthew J Meyer; Jodie M Fleming; Mustapha A Ali; Mitchell W Pesesky; Erika Ginsburg; Barbara K Vonderhaar
Journal:  Breast Cancer Res       Date:  2009-11-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.